{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T22:19:12Z","timestamp":1792880352229,"version":"4.5.0"},"reference-count":93,"publisher":"Association for Research in Vision and Ophthalmology (ARVO)","issue":"15","license":[{"start":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T00:00:00Z","timestamp":1765497600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Invest. Ophthalmol. Vis. Sci."],"published-print":{"date-parts":[[2025,12,12]]},"DOI":"10.1167\/iovs.66.15.38","type":"journal-article","created":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T14:01:01Z","timestamp":1765548061000},"page":"38","source":"Crossref","is-referenced-by-count":6,"title":["Overcoming Antimicrobial Resistance in Bacterial Keratitis With an Antibiotic-Eluting Contact Lens"],"prefix":"10.1167","volume":"66","author":[{"given":"Liangju","family":"Kuang","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Schepens Eye Research Institute of Mass Eye and Ear, Harvard Medical School, Boston, Massachusetts, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy E.","family":"Ross","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Schepens Eye Research Institute of Mass Eye and Ear, Harvard Medical School, Boston, Massachusetts, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Schepens Eye Research Institute of Mass Eye and Ear, Harvard Medical School, Boston, Massachusetts, United States"},{"name":"Department of Ophthalmology, Affiliated Hospital of Zunyi Medical University, Zunyi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Levi N.","family":"Kanu","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Schepens Eye Research Institute of Mass Eye and Ear, Harvard Medical School, Boston, Massachusetts, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolay","family":"Boychev","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Schepens Eye Research Institute of Mass Eye and Ear, Harvard Medical School, Boston, Massachusetts, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"Ghaffarieh","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Schepens Eye Research Institute of Mass Eye and Ear, Harvard Medical School, Boston, Massachusetts, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Peng","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Schepens Eye Research Institute of Mass Eye and Ear, Harvard Medical School, Boston, Massachusetts, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulo J. M.","family":"Bispo","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Massachusetts Eye and Ear; Infectious Disease Institute, Harvard Medical School, Boston, Massachusetts, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric G.","family":"Romanowski","sequence":"additional","affiliation":[{"name":"The Charles T. Campbell Ophthalmic Microbiology Laboratory, UPMC Vision Institute, Department of Ophthalmology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel S.","family":"Kohane","sequence":"additional","affiliation":[{"name":"Laboratory for Biomaterials and Drug Delivery, Dept. of Anesthesiology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph B.","family":"Ciolino","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Schepens Eye Research Institute of Mass Eye and Ear, Harvard Medical School, Boston, Massachusetts, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"27","reference":[{"key":"bib1","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1136\/bjophthalmol-2013-304660","article-title":"Topical antibiotics for the management of bacterial keratitis: an evidence-based review of high quality randomised controlled trials","volume":"98","author":"McDonald","year":"2014","journal-title":"Br J Ophthalmol"},{"key":"bib2","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.ajo.2020.03.017","article-title":"Methicillin-resistant Staphylococcus aureus keratitis: initial treatment, risk factors, clinical features, and treatment outcomes","volume":"214","author":"Durrani","year":"2020","journal-title":"Am J Ophthalmol"},{"key":"bib3","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1097\/ICO.0000000000002186","article-title":"Topical vancomycin 5% is more efficacious than 2.5% and 1.25% for reducing viable methicillin-resistant Staphylococcus aureus in infectious keratitis","volume":"39","author":"Romanowski","year":"2020","journal-title":"Cornea"},{"key":"bib4","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.survophthal.2018.12.003","article-title":"The persistent dilemma of microbial keratitis: global burden, diagnosis, and antimicrobial resistance","volume":"64","author":"Ung","year":"2019","journal-title":"Surv Ophthalmol"},{"key":"bib5","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.jtos.2017.06.001","article-title":"Emerging strategies for antimicrobial drug delivery to the ocular surface: implications for infectious keratitis","volume":"15","author":"Sharma","year":"2017","journal-title":"Ocul Surf"},{"key":"bib6","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.jconrel.2022.03.031","article-title":"Bibliometric and visualized analysis of ocular drug delivery from 2001 to 2020","volume":"345","author":"Peng","year":"2022","journal-title":"J Control Rel"},{"key":"bib7","doi-asserted-by":"publisher","first-page":"P1","DOI":"10.1016\/j.ophtha.2018.10.018","article-title":"Bacterial keratitis preferred practice pattern","volume":"126","author":"Lin","year":"2019","journal-title":"Ophthalmology"},{"key":"bib8","doi-asserted-by":"publisher","first-page":"119285","DOI":"10.1016\/j.biomaterials.2019.119285","article-title":"Topical sustained drug delivery to the retina with a drug-eluting contact lens","volume":"217","author":"Ross","year":"2019","journal-title":"Biomaterials"},{"key":"bib9","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1001\/archophthalmol.2009.96","article-title":"An objective evaluation of eyedrop instillation in patients with glaucoma","volume":"127","author":"Stone","year":"2009","journal-title":"Arch Ophthalmol"},{"key":"bib10","doi-asserted-by":"publisher","first-page":"114078","DOI":"10.1016\/j.addr.2021.114078","article-title":"Overcoming the rising incidence and evolving mechanisms of antibiotic resistance by novel drug delivery approaches\u2014an overview","volume":"181","author":"Lai","year":"2022","journal-title":"Adv Drug Deliv Rev"},{"key":"bib11","doi-asserted-by":"publisher","first-page":"S127","DOI":"10.1086\/428053","article-title":"Clinical Implications of pharmacokinetics and pharmacodynamics of fluoroquinolones","volume":"41","author":"Wispelwey","year":"2005","journal-title":"Clin Infect Dis"},{"key":"bib12","doi-asserted-by":"publisher","first-page":"eabo7793","DOI":"10.1126\/scitranslmed.abo7793","article-title":"The past, present, and future of antibiotics","volume":"14","author":"Cook","year":"2022","journal-title":"Sci Transl Med"},{"key":"bib13","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.ejps.2014.07.013","article-title":"Preparation and in vitro-in vivo evaluation of ofloxacin loaded ophthalmic nano structured lipid carriers modified with chitosan oligosaccharide lactate for the treatment of bacterial keratitis","volume":"63","author":"Ust\u00fcndag-Okur","year":"2014","journal-title":"Eur J Pharm Sci"},{"key":"bib14","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.jcis.2016.08.018","article-title":"Moxifloxacin loaded gelatin nanoparticles for ocular delivery: Formulation and in-vitro, in-vivo evaluation","volume":"483","author":"Mahor","year":"2016","journal-title":"J Colloid Interface Sci"},{"key":"bib15","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1021\/acs.biomac.1c00139","article-title":"Epithelium-penetrable nanoplatform with enhanced antibiotic internalization for management of bacterial keratitis","volume":"22","author":"Zhang","year":"2021","journal-title":"Biomacromolecules"},{"key":"bib16","doi-asserted-by":"publisher","first-page":"5230","DOI":"10.1021\/acs.biomac.3c00754","article-title":"Multifunctional polymer vesicles for synergistic antibiotic-antioxidant treatment of bacterial keratitis","volume":"24","author":"Chen","year":"2023","journal-title":"Biomacromolecules"},{"key":"bib17","doi-asserted-by":"publisher","first-page":"121558","DOI":"10.1016\/j.carbpol.2023.121558","article-title":"Carboxylated nanofibrillated cellulose empowers moxifloxacin to overcome Staphylococcus aureus biofilm in bacterial keratitis","volume":"324","author":"Malani","year":"2024","journal-title":"Carbohydr Polym"},{"key":"bib18","doi-asserted-by":"publisher","first-page":"17411","DOI":"10.1039\/D0NR03095C","article-title":"Nucleic acid peptide nanogels for the treatment of bacterial keratitis","volume":"12","author":"Obuobi","year":"2020","journal-title":"Nanoscale"},{"key":"bib19","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1002\/dta.170","article-title":"Ophthalmic delivery of sparfloxacin from in situ gel formulation for treatment of experimentally induced bacterial keratitis","volume":"3","author":"Nesseem","year":"2011","journal-title":"Drug Test Anal"},{"key":"bib20","first-page":"511","article-title":"Preparation and in vivo evaluation of in situ gel system as dual thermo-\/pH-responsive nanocarriers for sustained ocular drug delivery","volume":"32","author":"Davaran","year":"2015","journal-title":"J Microencapsul"},{"key":"bib21","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.3390\/polym14061135","article-title":"Nanoparticles loaded thermoresponsive in situ gel for ocular antibiotic delivery against bacterial keratitis","volume":"14","author":"Abbas","year":"2022","journal-title":"Polymers"},{"key":"bib22","first-page":"489","article-title":"Therapeutic Effectiveness in the Treatment of Experimental Bacterial Keratitis with Ion-activated Mucoadhesive Hydrogel","volume":"24","author":"Kesavan","year":"2016","journal-title":"Ocul Immunol Inflamm"},{"key":"bib23","first-page":"293","article-title":"All-small-molecule supramolecular hydrogels assembled from guanosine 5'-monophosphate disodium salt and tobramycin for the treatment of bacterial keratitis","volume":"16","author":"Cheng","year":"2022","journal-title":"Bioact Mater"},{"key":"bib24","doi-asserted-by":"publisher","first-page":"119552","DOI":"10.1016\/j.ijpharm.2020.119552","article-title":"Development of besifloxacin HCl loaded nanofibrous ocular inserts for the treatment of bacterial keratitis: In vitro, ex vivo and in vivo evaluation","volume":"585","author":"Polat","year":"2020","journal-title":"Int J Pharm"},{"key":"bib25","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1517\/17425247.2015.1059419","article-title":"Novel nanostructured lipid carrier-based inserts for controlled ocular drug delivery: evaluation of corneal bioavailability and treatment efficacy in bacterial keratitis","volume":"12","author":"\u00dcst\u00fcndag-Okur","year":"2015","journal-title":"Expert Opin Drug Deliv"},{"issue":"2","key":"bib26","doi-asserted-by":"publisher","first-page":"S143","DOI":"10.1097\/ICL.0000000000000421","article-title":"Release of moxifloxacin from corneal collagen shields","volume":"44(","author":"Zhou","year":"2018","journal-title":"Eye Contact Lens"},{"key":"bib27","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.1167\/iovs.12-10614","article-title":"Development and efficacy of a drug-releasing soft contact lens","volume":"54","author":"Kakisu","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib28","doi-asserted-by":"publisher","first-page":"3346","DOI":"10.1167\/iovs.08-2826","article-title":"A drug-eluting contact lens","volume":"50","author":"Ciolino","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib29","doi-asserted-by":"publisher","first-page":"4896","DOI":"10.1167\/iovs.14-14855","article-title":"In vitro and in vivo evaluation of novel ciprofloxacin-releasing silicone hydrogel contact lenses","volume":"55","author":"Hui","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib30","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.ijpharm.2019.05.031","article-title":"Evaluating the potential of drug eluting contact lenses for treatment of bacterial keratitis using an ex vivo corneal model","volume":"565","author":"Ubani-Ukoma","year":"2019","journal-title":"Int J Pharm"},{"key":"bib31","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.biomaterials.2017.01.046","article-title":"Development of ciprofloxacin-loaded contact lenses using fluorous chemistry","volume":"124","author":"Qin","year":"2017","journal-title":"Biomaterials"},{"key":"bib32","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.ijpharm.2018.06.059","article-title":"Contact lenses with dual drug delivery for the treatment of bacterial conjunctivitis","volume":"548","author":"Maulvi","year":"2018","journal-title":"Int J Pharm"},{"key":"bib33","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1021\/acsbiomaterials.1c01557","article-title":"Surface self-assembly construction of therapeutic contact lens with bacterial \u201ckill-releasing\u201d and drug-reloading capabilities for efficient bacterial keratitis treatment","volume":"8","author":"Wen","year":"2022","journal-title":"ACS Biomater Sci Eng"},{"key":"bib34","doi-asserted-by":"publisher","first-page":"e2300418","DOI":"10.1002\/mabi.202300418","article-title":"3D-Printed Inherently Antibacterial Contact Lens-Like Patches Carrying Antimicrobial Peptide Payload for Treating Bacterial Keratitis","volume":"24","author":"Ch","year":"2024","journal-title":"Macromol Biosci"},{"key":"bib35","doi-asserted-by":"publisher","first-page":"120023","DOI":"10.1016\/j.ijpharm.2020.120023","article-title":"Corneal delivery of moxifloxacin and dexamethasone combination using drug-eluting mucoadhesive contact lens to treat ocular infections","volume":"591","author":"Gade","year":"2020","journal-title":"Int J Pharm"},{"key":"bib36","doi-asserted-by":"publisher","first-page":"124505","DOI":"10.1016\/j.ijpharm.2024.124505","article-title":"Drug-impregnated contact lenses via supercritical carbon dioxide: a viable solution for the treatment of bacterial and fungal keratitis","volume":"662","author":"Gungor","year":"2024","journal-title":"Int J Pharm"},{"key":"bib37","doi-asserted-by":"publisher","first-page":"105591","DOI":"10.1016\/j.ejps.2020.105591","article-title":"Moxifloxacin-imprinted silicone-based hydrogels as contact lens materials for extended drug release","volume":"156","author":"Silva","year":"2021","journal-title":"Eur J Pharm Sci"},{"key":"bib38","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1167\/iovs.11-8215","article-title":"Sustained ocular delivery of ciprofloxacin using nanospheres and conventional contact lens materials","volume":"53","author":"Garhwal","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib39","doi-asserted-by":"publisher","first-page":"e70134","DOI":"10.1002\/pat.70134","article-title":"Moxifloxacin-impregnated contact lenses for treatment of keratitis in rabbit eyes","volume":"36","author":"Erdogan","year":"2025","journal-title":"Polym Adv Technol"},{"key":"bib40","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1016\/j.ophtha.2016.06.038","article-title":"Latanoprost-eluting contact lenses in glaucomatous monkeys","volume":"123","author":"Ciolino","year":"2016","journal-title":"Ophthalmology"},{"key":"bib41","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.biomaterials.2013.09.032","article-title":"In vivo performance of a drug-eluting contact lens to treat glaucoma for a month","volume":"35","author":"Ciolino","year":"2014","journal-title":"Biomaterials"},{"key":"bib42","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1097\/ICO.0000000000002711","article-title":"Dexamethasone-eluting contact lens for the prevention of postphotorefractive keratectomy scar in a New Zealand white rabbit model","volume":"40","author":"Soeken","year":"2021","journal-title":"Cornea"},{"key":"bib43","doi-asserted-by":"publisher","first-page":"2750","DOI":"10.3390\/pharmaceutics14122750","article-title":"Topical sustained delivery of miltefosine via drug-eluting contact lenses to treat acanthamoeba keratitis","volume":"14","author":"Chen","year":"2022","journal-title":"Pharmaceutics"},{"key":"bib44","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.actbio.2020.08.013","article-title":"Steroid-eluting contact lenses for corneal and intraocular inflammation","volume":"116","author":"Bengani","year":"2020","journal-title":"Acta Biomater"},{"key":"bib45","doi-asserted-by":"publisher","first-page":"101487","DOI":"10.1016\/j.clae.2021.101487","article-title":"Pharmaceutical-loaded contact lenses as an ocular drug delivery system: A review of critical lens characterization methodologies with reference to ISO standards","volume":"44","author":"Nguyen","year":"2021","journal-title":"Contact Lens Anterior Eye"},{"key":"bib46","doi-asserted-by":"publisher","first-page":"S32","DOI":"10.1016\/j.survophthal.2005.07.001","article-title":"Ocular pharmacokinetics of moxifloxacin after topical treatment of animals and humans","volume":"50","author":"Robertson","year":"2005","journal-title":"Surv Ophthalmol"},{"key":"bib47","first-page":"100023","article-title":"Premium ethylcellulose polymer based architectures at work in drug delivery","volume":"1","author":"Adeleke","year":"2019","journal-title":"Int J Pharm"},{"key":"bib48","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1080\/10731190600769701","article-title":"In vitro and in vivo degradation of oxidized acetyl- and ethyl-cellulose sponges","volume":"34","author":"El\u00e7in","year":"2006","journal-title":"Artif Cells Blood Substit Immobil Biotechnol"},{"key":"bib49","first-page":"100023","article-title":"Premium ethylcellulose polymer based architectures at work in drug delivery","volume":"1","author":"Adeleke","year":"2019","journal-title":"Int J Pharm"},{"key":"bib50","doi-asserted-by":"publisher","first-page":"47212","DOI":"10.1002\/app.47212","article-title":"Bioinspired glycosaminoglycan hydrogels via click chemistry for 3D dynamic cell encapsulation","volume":"136","author":"Kuang","year":"2019","journal-title":"J Appl Polym Sci"},{"key":"bib51","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1167\/tvst.10.14.5","article-title":"Controlled release of multiple therapeutics from silicone hydrogel contact lenses for post-cataract\/post-refractive surgery and uveitis treatment","volume":"10","author":"DiPasquale","year":"2021","journal-title":"Transl Vis Sci Technol"},{"key":"bib52","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.clae.2016.11.005","article-title":"Mechanical properties of contact lenses: The contribution of measurement techniques and clinical feedback to 50 years of materials development","volume":"40","author":"Bhamra","year":"2017","journal-title":"Contact Lens Anterior Eye"},{"key":"bib53","doi-asserted-by":"publisher","first-page":"15","DOI":"10.14227\/DT040497P15","article-title":"FDA guidance for industry: dissolution testing of immediate release solid oral dosage forms","volume":"4","author":"Shah","year":"1997","journal-title":"Dissolution Technol"},{"key":"bib55","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/S0891-5520(20)30528-6","article-title":"Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically","volume":"7","author":"Jorgensen","year":"1993","journal-title":"Infect Dis Clin North Am"},{"key":"bib56","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/j.ajo.2005.01.021","article-title":"The successful treatment of gatifloxacin-resistant Staphylococcus aureus keratitis with Zymar (gatifloxacin 0.3%) in a NZW rabbit model","volume":"139","author":"Romanowski","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"bib57","doi-asserted-by":"publisher","first-page":"e120","DOI":"10.1111\/j.1755-3768.2010.01897.x","article-title":"Topical levofloxacin 1.5% overcomes in vitro resistance in rabbit keratitis models","volume":"88","author":"Kowalski","year":"2010","journal-title":"Acta Ophthalmol"},{"key":"bib58","first-page":"2430","article-title":"Effect of metalloproteinase inhibitor on corneal cytokine expression after alkali injury","volume":"40","author":"Sotozono","year":"1999","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib59","first-page":"1953","article-title":"Cytokine expression during orthotopic corneal allograft rejection in mice","volume":"39","author":"Sano","year":"1998","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib60","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.3109\/02713689008997584","article-title":"The role of pneumolysin in ocular infections with Streptococcus pneumoniae","volume":"9","author":"Johnson","year":"1990","journal-title":"Curr Eye Res"},{"key":"bib61","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/S0039-6257(01)00211-9","article-title":"The Draize eye test","volume":"45","author":"Wilhelmus","year":"2001","journal-title":"Surv Ophthalmol"},{"key":"bib62","doi-asserted-by":"publisher","first-page":"2351","DOI":"10.1021\/acs.biomac.8b00517","article-title":"Pharmaceutical applications of cellulose ethers and cellulose ether esters","volume":"19","author":"Arca","year":"2018","journal-title":"Biomacromolecules"},{"key":"bib63","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/sj.neo.7900071","article-title":"Optical coherence tomography: an emerging technology for biomedical imaging and optical biopsy","volume":"2","author":"Fujimoto","year":"2000","journal-title":"Neoplasia"},{"key":"bib64","doi-asserted-by":"publisher","first-page":"10778","DOI":"10.1021\/acsnano.5b04306","article-title":"Mesoporous silica nanoparticles with ph-sensitive nanovalves for delivery of moxifloxacin provide improved treatment of lethal pneumonic tularemia","volume":"9","author":"Li","year":"2015","journal-title":"ACS Nano"},{"key":"bib65","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1001\/archopht.1989.01070020445052","article-title":"Collagen shield enhancement of topical dexamethasone penetration","volume":"107","author":"Hwang","year":"1989","journal-title":"Arch Ophthalmol"},{"key":"bib66","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1097\/ICO.0b013e31828d6d9e","article-title":"Comparative intraocular penetration of 4 fluoroquinolones after topical instillation","volume":"32","author":"Chung","year":"2013","journal-title":"Cornea"},{"key":"bib67","doi-asserted-by":"publisher","first-page":"101725","DOI":"10.1016\/j.clae.2022.101725","article-title":"The clinical treatment of bacterial keratitis: A review of drop instillation regimes","volume":"45","author":"Pearce","year":"2022","journal-title":"Contact Lens Anterior Eye"},{"key":"bib68","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1016\/j.ophtha.2006.12.011","article-title":"Clinical efficacy of moxifloxacin in the treatment of bacterial keratitis: a randomized clinical trial","volume":"114","author":"Constantinou","year":"2007","journal-title":"Ophthalmology"},{"key":"bib69","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1089\/jop.2009.0121","article-title":"Efficacy of besifloxacin in an early treatment model of methicillin-resistant Staphylococcus aureus keratitis","volume":"26","author":"Sanders","year":"2010","journal-title":"J Ocul Pharmacol Ther"},{"key":"bib70","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1167\/iovs.02-0548","article-title":"Phospholipase A2 activity in normal and Staphylococcus aureus-infected rabbit eyes","volume":"44","author":"Girgis","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib71","doi-asserted-by":"publisher","first-page":"121227","DOI":"10.1016\/j.biomaterials.2021.121227","article-title":"Vision redemption: self-reporting AIEgens for combined treatment of bacterial keratitis","volume":"279","author":"Peng","year":"2021","journal-title":"Biomaterials"},{"key":"bib72","first-page":"125","article-title":"The source of proteins in the aqueous humor of the normal rabbit","volume":"31","author":"Freddo","year":"1990","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib73","first-page":"1199","article-title":"Effects of transcorneal freezing on protein content of aqueous humor and intraocular temperature in rabbit and cat","volume":"17","author":"Buco","year":"1978","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib74","doi-asserted-by":"publisher","first-page":"2442","DOI":"10.1128\/AAC.46.8.2442-2449.2002","article-title":"Immunomodulatory and protective effects of moxifloxacin against Candida albicans-induced bronchopneumonia in mice injected with cyclophosphamide","volume":"46","author":"Shalit","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"bib75","doi-asserted-by":"publisher","first-page":"6612","DOI":"10.1167\/iovs.15-16560","article-title":"Contralateral clinically unaffected eyes of patients with unilateral infectious keratitis demonstrate a sympathetic immune response","volume":"56","author":"Cruzat","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib76","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1080\/02713680802478704","article-title":"Anti-inflammatory effects of besifloxacin, a novel fluoroquinolone, in primary human corneal epithelial cells","volume":"33","author":"Zhang","year":"2008","journal-title":"Curr Eye Res"},{"key":"bib77","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.clae.2013.09.004","article-title":"UV\u2013vis light transmittance through tinted contact lenses and the effect of color on values","volume":"37","author":"Osuagwu","year":"2014","journal-title":"Contact Lens Anterior Eye"},{"key":"bib78","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.ajo.2011.06.023","article-title":"Micrometer-scale contact lens movements imaged by ultrahigh-resolution optical coherence tomography","volume":"153","author":"Cui","year":"2012","journal-title":"Am J Ophthalmol"},{"key":"bib79","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.clae.2015.11.001","article-title":"How should initial fit inform soft contact lens prescribing","volume":"39","author":"Boychev","year":"2016","journal-title":"Contact Lens Anterior Eye"},{"key":"bib80","doi-asserted-by":"publisher","first-page":"191613","DOI":"10.1098\/rsos.191613","article-title":"Regulation of pupil size in natural vision across the human lifespan","volume":"11","author":"Lazar","year":"2024","journal-title":"R Soc Open Sci"},{"key":"bib81","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/1120009X.2004.11782371","article-title":"The role of PK\/PD parameters to avoid selection and increase of resistance: mutant prevention concentration","volume":"16","author":"Blondeau","year":"2004","journal-title":"J Chemother"},{"key":"bib82","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/s41467-021-27193-9","article-title":"Hydrophilic nanoparticles that kill bacteria while sparing mammalian cells reveal the antibiotic role of nanostructures","volume":"13","author":"Jiang","year":"2022","journal-title":"Nat Commun"},{"key":"bib83","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1021\/acsinfecdis.7b00076","article-title":"Hydrophilic phage-mimicking membrane active antimicrobials reveal nanostructure-dependent activity and selectivity","volume":"3","author":"Jiang","year":"2017","journal-title":"ACS Infect Dis"},{"key":"bib84","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.colsurfb.2019.05.007","article-title":"Acetylcysteine-decorated Prussian blue nanoparticles for strong photothermal sterilization and focal infection treatment","volume":"181","author":"Cai","year":"2019","journal-title":"Colloids Surf B Biointerfaces"},{"key":"bib85","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.jconrel.2020.09.014","article-title":"Biofilm microenvironment activated supramolecular nanoparticles for enhanced photodynamic therapy of bacterial keratitis","volume":"327","author":"Han","year":"2020","journal-title":"J Control Rel"},{"key":"bib86","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1089\/jop.2008.0116","article-title":"Ocular pharmacokinetics of besifloxacin following topical administration to rabbits, monkeys, and humans","volume":"25","author":"Proksch","year":"2009","journal-title":"J Ocul Pharmacol Ther"},{"key":"bib87","doi-asserted-by":"publisher","first-page":"6250","DOI":"10.1038\/s41598-021-85834-x","article-title":"Evaluation of moxifloxacin-induced cytotoxicity on human corneal endothelial cells","volume":"11","author":"Park","year":"2021","journal-title":"Sci Rep"},{"key":"bib88","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1097\/ICO.0b013e3180515251","article-title":"Comparison of antibiotic effect and corneal epithelial toxicity of levofloxacin and moxifloxacin in vitro","volume":"26","author":"Kim","year":"2007","journal-title":"Cornea"},{"key":"bib89","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1016\/j.jcrs.2014.08.027","article-title":"Comparison of toxicities of moxifloxacin, cefuroxime, and levofloxacin to corneal endothelial cells in vitro","volume":"40","author":"Haruki","year":"2014","journal-title":"J Cataract Refract Surg"},{"key":"bib90","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1097\/ICO.0000000000000967","article-title":"Toxicity of intracameral injection of fourth-generation fluoroquinolones on the corneal endothelium","volume":"35","author":"FB","year":"2016","journal-title":"Cornea"},{"key":"bib91","doi-asserted-by":"publisher","first-page":"11","DOI":"10.4103\/0974-620X.176094","article-title":"Eye drop administration in patients attending and not attending a glaucoma education center","volume":"9","author":"Al-Busaidi","year":"2016","journal-title":"Oman J Ophthalmol"},{"key":"bib93","doi-asserted-by":"publisher","first-page":"2478","DOI":"10.1128\/iai.62.6.2478-2482.1994","article-title":"Corneal virulence of Staphylococcus aureus: roles of alpha-toxin and protein A in pathogenesis","volume":"62","author":"Callegan","year":"1994","journal-title":"Infect Immun"},{"key":"bib54","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/B978-0-12-369521-5.00010-5","article-title":"Chapter 10 - Pharmacokinetic Modeling","volume-title":"Pharmacology","author":"Byers","year":"2009"},{"key":"bib92","volume-title":"In vitro combinatory antimicrobial effect of crude bacteriocins from Pediococcus pentosaceus strains and selected antibiotics against Pseudomonas aeruginosa ATCC 10145 [doctoral dissertation]","author":"Suffian","year":"2020"}],"container-title":["Investigative Ophthalmology &amp; Visual Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/iovs.arvojournals.org\/article.aspx?articleid=2811208","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:32:04Z","timestamp":1791927124000},"score":1,"resource":{"primary":{"URL":"https:\/\/iovs.arvojournals.org\/article.aspx?articleid=2811208"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,12]]},"references-count":93,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2025,12,1]]}},"URL":"https:\/\/doi.org\/10.1167\/iovs.66.15.38","relation":{},"ISSN":["1552-5783"],"issn-type":[{"value":"1552-5783","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12,12]]}}}